VMP 42274511000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Mirtazapine 15mg tablets
BNF code 0403040X0AAANAN
Virtual Therapeutic Moiety Mirtazapine
Date identifier became valid 22 Sep 2023
Previous product identifier 375193003
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Mirtazapine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 15.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Mirtazapine 15mg tablets (AAH Hillcross)
Mirtazapine 15mg tablets (A A H Pharmaceuticals Ltd)
Mirtazapine 15mg tablets (Accord-UK Ltd)
Mirtazapine 15mg tablets (Alliance Healthcare (Distribution) Ltd)
Mirtazapine 15mg tablets (Almus Pharmaceuticals Ltd)
Mirtazapine 15mg tablets (Genesis Pharmaceuticals Ltd)
Mirtazapine 15mg tablets (Medihealth (Northern) Ltd)
Mirtazapine 15mg tablets (Medreich Plc)
Mirtazapine 15mg tablets (Milpharm Ltd)
Mirtazapine 15mg tablets (Noumed Life Sciences Ltd)
Mirtazapine 15mg tablets (Phoenix Healthcare Distribution Ltd)
Mirtazapine 15mg tablets (Relonchem Ltd)
Mirtazapine 15mg tablets (Sigma Pharmaceuticals Plc)
Mirtazapine 15mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Mirtazapine 15mg tablets 28 tablet
Mirtazapine 15mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback